Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
University of California, San Francisco
NiKang Therapeutics, Inc.
Shanghai Zhongshan Hospital
Arsenal Biosciences, Inc.
University of Pittsburgh
Hoffmann-La Roche